Bruker Corporation (NASDAQ: BRKR) has reported E.P.S. of $0.35 for its first fiscal quarter (ending March 31) versus $0.52 for the same period a year ago — a decline of -33%. This result fell short of the consensus estimate of $0.69 by $-0.34. For the latest four quarters through March 31, E.P.S. were $2.75 versus $2.11 for the same period a year ago — an increase of 30%.
Recent Price Action
Bruker Corporation (NASDAQ: BRKR) stock closed at $70.09 on 5/2/24 after a major decline of -11.3%. Moreover, this decline was accompanied by exceptionally high trading volume at 390% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -14.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, BRKR is expected to continue to be a major Value Builder.
Bruker has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Bruker has a poor Appreciation Score of 28 but a very high Power Rating of 88, and the High Neutral Value Trend Rating results.
Rating Review
In light of this new information and highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment